These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 7371708)
21. Generating high-quality clinical evidence in palliative care using n-of-1 trials. Mitchell GK J Palliat Med; 2010 Oct; 13(10):1185-6. PubMed ID: 20942759 [No Abstract] [Full Text] [Related]
22. Dry eye syndromes: treatment and clinical trials. Lemp MA Adv Exp Med Biol; 1994; 350():553-9. PubMed ID: 8030535 [No Abstract] [Full Text] [Related]
23. Interpreting HIV clinical trials. Glesby MJ AIDS Clin Care; 1999 Jul; 11(7):58-9. PubMed ID: 11366435 [TBL] [Abstract][Full Text] [Related]
24. The clinician as investigator: participating in clinical trials in the practice setting: Appendix 1: fundamentals of study design. Lader EW; Cannon CP; Ohman EM; Newby LK; Sulmasy DP; Barst RJ; Fair JM; Flather M; Freedman JE; Frye RL; Hand MM; Jesse RL; Van de Werf F; Costa F; Circulation; 2004 Jun; 109(21):e302-4. PubMed ID: 15173052 [No Abstract] [Full Text] [Related]
26. Bias. Rose G Br J Clin Pharmacol; 1982 Feb; 13(2):157-62. PubMed ID: 7059412 [No Abstract] [Full Text] [Related]
27. [How blind is a double-blind trial really? Validity of controlled investigations]. Modestin J; Hodel J Int Pharmacopsychiatry; 1977; 12(3):129-36. PubMed ID: 334685 [TBL] [Abstract][Full Text] [Related]
28. Nonfatal myocardial infarction is, by itself, an inappropriate end point in clinical trials in cardiology. Fleiss JL; Bigger JT; McDermott M; Miller JP; Moon T; Moss AJ; Oakes D; Rolnitzky LM; Therneau TM Circulation; 1990 Feb; 81(2):684-5. PubMed ID: 2297869 [No Abstract] [Full Text] [Related]
29. Further statistics in dentistry. Part 3: Clinical trials 1. Petrie A; Bulman JS; Osborn JF Br Dent J; 2002 Nov; 193(9):495-8. PubMed ID: 12572733 [No Abstract] [Full Text] [Related]
30. Dropouts and missing data in psychiatric clinical trials. Potkin SG; Siu CO Am J Psychiatry; 2009 Nov; 166(11):1295; author reply 1295-6. PubMed ID: 19884237 [No Abstract] [Full Text] [Related]
31. Placebos and controlled trials under attack. Lasagna L Eur J Clin Pharmacol; 1979 Jul; 15(6):373-4. PubMed ID: 499286 [No Abstract] [Full Text] [Related]
32. Study design. Shott S J Am Vet Med Assoc; 1990 Nov; 197(9):1142-4. PubMed ID: 2254138 [No Abstract] [Full Text] [Related]
33. Assessment of blinding may be inappropriate after the trial. Hemilä H Contemp Clin Trials; 2005 Aug; 26(4):512-4; author reply 514-5. PubMed ID: 15951244 [No Abstract] [Full Text] [Related]
34. The double-blind in danger: untoward consequences of informed consent. Brownell KD; Stunkard AJ Am J Psychiatry; 1982 Nov; 139(11):1487-9. PubMed ID: 6753613 [TBL] [Abstract][Full Text] [Related]
35. Masking the readers may ensure objective judgment about clinical trials. Bang A Control Clin Trials; 1991 Aug; 12(4):553-5. PubMed ID: 1657530 [No Abstract] [Full Text] [Related]
36. Perspectives on clinical trials in the rheumatic diseases. Hart FD Clin Rheum Dis; 1983 Dec; 9(3):491-8. PubMed ID: 6606529 [No Abstract] [Full Text] [Related]
37. Open-label surgical trials for Parkinson disease: time for reconsideration. Alterman RL; Tagliati M; Olanow CW Ann Neurol; 2011 Jul; 70(1):5-8. PubMed ID: 21786295 [No Abstract] [Full Text] [Related]